In the case of the irregular respiratory rhythms present in patients with Rett syndrome, pre-clinical studies in MeCP2-deficient mice developed strong evidence that drugs targeting serotonergic and dopaminergic receptors were effective to correct respiratory disturbances (Abdala et al., 2013; Abdala et al., 2010). The gene discussed is MECP2; the disease is atypical Rett syndrome.